Document details

Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro

Author(s): Morais, Inês ; Medeiros, Márcia M. ; de Carvalho, Maria ; Morello Bullon, Judit ; M. Teixeira, Sara ; Maciel, Suelma ; Nhantumbo, Janice ; Balau, Ana ; T.G. Rosa, Margarida ; Nogueira, Fatima ; A. Rodrigues, João ; Carvalho, Filomena A. ; Antunes, Alexandra M M ; Arez, Ana Paula

Date: 2022

Persistent ID: http://hdl.handle.net/10362/140652

Origin: Repositório Institucional da UNL

Subject(s): Malaria; Host-parasite interactions; Red blood cell; 2,3-DPG; Glycolysis; Pyruvate kinase deficiency; 2,3-BPG; Biochemistry, Genetics and Molecular Biology (miscellaneous); Applied Microbiology and Biotechnology; Parasitology; Biochemistry, medical; Epidemiology; Pharmacology, Toxicology and Pharmaceutics (miscellaneous); SDG 1 - No Poverty; SDG 3 - Good Health and Well-being; SDG 9 - Industry, Innovation, and Infrastructure; SDG 10 - Reduced Inequalities; Malaria; Malaria; Host-parasite interactions; Host-parasite interactions; Red blood cell; Red blood cell; 2,3-DPG; 2,3-DPG; Glycolysis; Glycolysis; Pyruvate kinase deficiency; Pyruvate kinase deficiency; 2,3-BPG; 2,3-BPG; Biochemistry, Genetics and Molecular Biology (miscellaneous); Biochemistry, Genetics and Molecular Biology (miscellaneous); Applied Microbiology and Biotechnology; Applied Microbiology and Biotechnology; Parasitology; Parasitology; Biochemistry, medical; Biochemistry, medical; Epidemiology; Epidemiology; Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous); SDG 1 - No Poverty; SDG 1 - No Poverty; SDG 3 - Good Health and Well-being; SDG 3 - Good Health and Well-being; SDG 9 - Industry, Innovation, and Infrastructure; SDG 9 - Industry, Innovation, and Infrastructure; SDG 10 - Reduced Inequalities; SDG 10 - Reduced Inequalities


Description

Mechanisms of malaria parasite interaction with its host red blood cell may provide potential targets for new antimalarial approaches. Pyruvate kinase deficiency has been associated with resistance to malaria in both experimental models and population studies. Two of the major pyruvate kinase deficient-cell disorders are the decrease in ATP and the increase in 2,3-biphosphoglycerate (2,3-BPG) concentration. High levels of this metabolite, only present in mammalian red blood cell, has an inhibitory effect on glycolysis and we hypothesized that its accumulation may also be harmful to the parasite and be involved in the mechanism of protection provided by that enzymopathy. We examined the effect of a synthetic form, 2,3-DPG, on the Plasmodium falciparum intraerythrocytic developmental cycle in vitro. Results showed an impairment of parasite growth with a direct effect on parasite maturation as significant lower progeny emerged from parasites that were submitted to 2,3-DPG. Further, adding the compound to the culture medium did not result in any effect on the host cell, but instead the metabolic profile of an infected cell became closer to that of a non-infected cell.

Document Type Journal article
Language English
Contributor(s) Instituto de Higiene e Medicina Tropical (IHMT); Global Health and Tropical Medicine (GHTM); Vector borne diseases and pathogens (VBD); Centro de Estudos de Doenças Crónicas (CEDOC); NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM); RUN
facebook logo  linkedin logo  twitter logo 
mendeley logo

Related documents

No related documents